Category: Myeloma

Home / Established Year

NMPA approves zevorcabtagene autoleucel CAR T Cell therapy for R/R multiple myeloma

NMPA approves zevorcabtagene autoleucel CAR T Cell therapy for R/R multiple myeloma

Zevor-Cel therapy Chinese regulators have approved zevorcabtagene autoleucel (zevor-cel; CT053), an autologous CAR T-cell therapy, for the treatment of adult patients with multiple myeloma that has relapsed or is no longer respon..

FasTCAR-T GC012F demonstrated overall 100% response rate in newly diagnosed multiple myeloma

FasTCAR-T GC012F demonstrated overall 100% response rate in newly diagnosed multiple myeloma

Introduction Even in transplant-eligible (TE) patients, typical first-line treatments for high-risk (HR) newly-diagnosed multiple myeloma (NDMM) have dismal outcomes. A high-efficacy, safe CAR-T treatment could address this large..

Is Blood Cancer Curable- Find Blood Cancer Treatment Success Rate

The Life-Changing Treatment for Blood Cancer Finally Exposed!

Blood cancer is a type of cancer that affects both the blood and bone marrow. It is the fifth most common type of cancer in the world, with around 1.24 million new cases diagnosed each year. Wondering is blood cancer curable? Fin..

FUCASO treatment for multiple myeloma in China

NMPA Approves FUCASO: Multiple Myeloma Treatment In China

FUCASO treatment in China The overall response rate of this revolutionary cancer therapy named FUCASO is 96%. The NMPA's approval marks a turning point in China's fight against multiple myeloma. This blog explores the effective..

Free Cancer Treatment In China For Those Who Can’t Afford It

Free Cancer Treatment In China Without Breaking The Bank: A Guide For Those Who Need It Most

Free cancer treatment in China is providing hope and healing to people in need. So, if you are unable to opt for cancer treatment because of its extensive cost, this guide is specially meant for you. Find out how reputed organiz..

early signs and symptoms of multiple myeloma

An Informative Guide On The Whispering Signs And Symptoms Of Multiple Myeloma

Read our guide to learn about the silent indicators of multiple myeloma. Learn to spot them early, so you can make smart choices for your health. Don't ignore the warning signs, empower yourself with knowledge and take charge..

A Closer Look At The Various Stages Of Multiple Myeloma

A Closer Look At The Various Stages Of Multiple Myeloma

Learn about the different stages and types of multiple myeloma. Find hope and support with information on treatments and coping strategies. This simple guide can help you take charge of your health and fight against multiple myel..

Diagnostic Imaging In Multiple Myeloma
,

How Does Diagnostic Imaging Save Lives in Multiple Myeloma Battles?

Curious about how a medical technique is saving the lives of multiple myeloma patients? Read our blog to learn more about this life-saving technique! Let's turn the page on cancer together. Your story of hope starts here. Hell..

Elranatamab-bcmm receives approval for the treatment of multiple myeloma
, ,

Elranatamab-bcmm receives accelerated approval by FDA for multiple myeloma

Nov 2023: Elranatamab-bcmm (Elrexfio, Pfizer, Inc.) is a bispecific B-cell maturation antigen (BCMA)-directed CD3 T-cell engager that was given accelerated approval by the Food and Drug Administration for adults with relapsed or ..

Talvey-Janssen
, , , ,

Talquetamab-tgvs has received accelerated approval for relapsed or refractory multiple myeloma

August 2023: Talquetamab-tgvs (Talvey, Janssen Biotech, Inc.) has been given accelerated approval by the Food and Drug Administration for the treatment of adults with relapsed or refractory multiple myeloma who have undergone at ..

Newer
Start chat
We Are Online! Chat With Us!
Scan the code
Hello,

Welcome to CancerFax !

CancerFax is a pioneering platform dedicated to connecting individuals facing advanced-stage cancer with groundbreaking cell therapies like CAR T-Cell therapy, Gene therapy, TIL therapy, and clinical trials worldwide.

Let us know what we can do for you.

1) CAR T-Cell therapy
2) Gene therapy
3) Gamma-Delta T Cell therapy
4) TIL therapy
5) NK Cell therapy